ArticleInflammopharmacology2024

Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression.

Parviz Soufivand et al.PubMed ↗Publisher ↗

No numbers read from the abstract.